July 18, 2017 / 2:38 PM / 3 months ago

BRIEF-Philip Renaud says Renaud, entity over which he exercises control now own about 30.56 pct of shares of Kane Biotech

July 18 (Reuters) - Philip Renaud:

* Says acquired 12.5 million units of Kane Biotech in connection with corporation’s previously announced non-brokered private placement

* Philip Renaud is chairman and a director of Kane Biotech Inc

* Renaud and entity over which Renaud exercises control now own about 30.56 percent of current issued and outstanding shares of Kane Biotech

* Renaud, entity over which he exercises control have no current intention to acquire ownership/control over additional securities of Kane Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below